🇺🇸 FDA
Pipeline program

Lu AF28996 in Patients With Parkinson's Disease

18252A

Phase 1 other active

Quick answer

Lu AF28996 in Patients With Parkinson's Disease for Parkinson's Disease is a Phase 1 program (other) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
H. Lundbeck A/S
Indication
Parkinson's Disease
Phase
Phase 1
Modality
other
Status
active

Clinical trials